Atlas Trials

To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods

RecordFirmDate
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC) (NCT03816657)Fondazione Ricerca Traslazionale2015-02-15

Track To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods automatically

Every clearance here is in the API, with alerts when new ones post.